BCL6 and neoplasm: Previous studies demonstrate that BCL6 is degraded via the ubiquitin-proteosome system (23, 24) and its degradation is balanced by FBXO11 (23) and AIP (25) thus regulating the tumor growth of diffuse large B cell lymphoma.